Stephens & Co. Reiterates Overweight on Addus HomeCare, Maintains $115 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel reiterated an Overweight rating on Addus HomeCare (NASDAQ:ADUS) and maintained a $115 price target.
May 07, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stephens & Co. reaffirmed an Overweight rating on Addus HomeCare with a $115 price target.
The reiteration of an Overweight rating and a $115 price target by Stephens & Co. suggests a positive outlook on Addus HomeCare's stock, potentially leading to increased investor confidence and a positive short-term price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100